Stockwatch

Unidoc Health Corp
Symbol	UDOC
Shares Issued	10,933,350
Close 2023-06-26	C$ 0.57
Market Cap	C$ 6,232,010
Recent Sedar+ Documents

Unidoc receives H3 Health Cube trademark in EU

2023-06-26 09:25 ET - News Release

Subject: UniDoc Health (CSE:UDOC) News Word Document File: '\\swfile\EmailIn\20230626 055018 Attachment UDOC_June_26_23 - Trademark v2.docx' UniDoc Receives European Trademark Approval VANCOUVER, British Columbia, June 26, 2023 -- UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) ("UniDoc," or the "Company"), an innovator in the telehealth sector, is pleased to announce the grants of European Union Intellectual Property Office registration number 1704468. The trademark includes the H3 Health Cube logo and wording. CEO of UniDoc, Antonio Baldassare, states, "UniDoc's receipt of the H3 Health Cube trademark will allow us to secure our brand identity in the European Market. Our partner, Hewlett Packard, secured their first Italian order. The European market is becoming a focus for the company and a strong and protected brand identity is crucial to our efforts there." The H3 Health Cube is UniDoc's leading Virtual Care Solution kiosk and is specifically designed to meet European disabilities standards for accessible design and related international equivalents. The H3 will be large enough to allow for technologies requiring enhanced privacy and advanced technical capability which may require a trained technician within the booth to assist the remote practitioner and patient. Each H3 Health Cube offers UV-C self sanitization and easy clean surfaces for protection against the spread of bacteria and viral infections. The H3 cube provides full privacy, adjustable lighting, modular expandability to accommodate multiple diagnostic technical packages, robust internet connectivity, electrical distribution with water and compressed air or mixed gas options, climate control and enclosure designs suited for either indoor or outdoor environments. The Company also advises it has granted an aggregate of 1,073,000 stock options ("Options") to certain directors, officers, and consultants of the Company, each being exercisable for one common share of the Company at a price of $0.60 for a period of two years from the date of grant. On Behalf of the Board of Directors, ~Antonio Baldassarre~ Antonio Baldassarre CEO, President & Director UniDoc Health Corp. About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) UniDoc is developing a telehealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician's office. Telehealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company's belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress. You are also invited to join us on social media with Facebook, Twitter or Instagram. For further information, please contact: UniDoc Investor Relations Tel: +1 778.383.6731 Email: info@unidoctor.com Matt Chatterton, Director Tel: +1 778.613.2082 Email: matt@unidoctor.com Media Inquiries media@unidoctor.com Forward-Looking Statements This news release contains statements and information that, to the extent that they are not historical fact, may constitute "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as "may", "would", "could", "will", "will be", "likely", "except", "anticipate", "believe", "intend", "plan", "forecast", "project", "estimate", "outlook", or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the receipt of the H3 Health Cube trademark allowing the Company to secure its brand identity in Europe. Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company's ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all; as well as all of the other risks as described in the Company's annual management discussion and analysis dated July 29, 2022 under the heading "Risks Factors." Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company's management to predict all such factors and to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws. The CSE does not accept responsibility for the adequacy or accuracy of this release.